<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A67F0D66-6EB6-4F78-8AD7-2116C54EF353"><gtr:id>A67F0D66-6EB6-4F78-8AD7-2116C54EF353</gtr:id><gtr:name>Arthritis Research UK</gtr:name><gtr:address><gtr:line1>Copeman House</gtr:line1><gtr:line2>St Marys Court</gtr:line2><gtr:line3>St Marys Gate</gtr:line3><gtr:postCode>S41 7TD</gtr:postCode><gtr:region>East Midlands</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FC6D5C1C-A335-4CDA-82AC-114FCC39A0EF"><gtr:id>FC6D5C1C-A335-4CDA-82AC-114FCC39A0EF</gtr:id><gtr:name>Royal National Orthopaedic Hospital NHS Trust</gtr:name><gtr:address><gtr:line1>Brockley Hill</gtr:line1><gtr:city>Stanmore</gtr:city><gtr:postCode>HA7 4LP</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/666A7C6D-E59C-4C37-8997-490B93914C41"><gtr:id>666A7C6D-E59C-4C37-8997-490B93914C41</gtr:id><gtr:name>MRC Clinical Trials Unit</gtr:name><gtr:address><gtr:line1>Aviation House</gtr:line1><gtr:line2>125 Kingsway</gtr:line2><gtr:postCode>WC2B 6NH</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/666A7C6D-E59C-4C37-8997-490B93914C41"><gtr:id>666A7C6D-E59C-4C37-8997-490B93914C41</gtr:id><gtr:name>MRC Clinical Trials Unit</gtr:name><gtr:address><gtr:line1>Aviation House</gtr:line1><gtr:line2>125 Kingsway</gtr:line2><gtr:postCode>WC2B 6NH</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A67F0D66-6EB6-4F78-8AD7-2116C54EF353"><gtr:id>A67F0D66-6EB6-4F78-8AD7-2116C54EF353</gtr:id><gtr:name>Arthritis Research UK</gtr:name><gtr:address><gtr:line1>Copeman House</gtr:line1><gtr:line2>St Marys Court</gtr:line2><gtr:line3>St Marys Gate</gtr:line3><gtr:postCode>S41 7TD</gtr:postCode><gtr:region>East Midlands</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FC6D5C1C-A335-4CDA-82AC-114FCC39A0EF"><gtr:id>FC6D5C1C-A335-4CDA-82AC-114FCC39A0EF</gtr:id><gtr:name>Royal National Orthopaedic Hospital NHS Trust</gtr:name><gtr:address><gtr:line1>Brockley Hill</gtr:line1><gtr:city>Stanmore</gtr:city><gtr:postCode>HA7 4LP</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/C0D1CA6E-1770-4AA4-9EC0-55336CC1D676"><gtr:id>C0D1CA6E-1770-4AA4-9EC0-55336CC1D676</gtr:id><gtr:firstName>Caroline</gtr:firstName><gtr:surname>Dore</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U122886349"><gtr:id>1C54ED3E-493E-4200-B5EB-4D4430983293</gtr:id><gtr:title>Improving prevention and treatment for patients with musculoskeletal conditions</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U122886349</gtr:grantReference><gtr:abstractText>VIDEO and PACINO are two of our current clinical trials which aim to find better ways of treating patients with musculoskeletal conditions.||In the VIDEO trial patients with osteoarthritis of the knee are randomised to either daily Vitamin D or placebo capsules for three years. We want to find out whether Vitamin D will slow down the rate of narrowing of the joint space width in the knee. Patients have X-rays of their knee at the start of the trial and after three years of therapy and complete regular questionnaires describing their pain and disability. If Vitamin D is found to be effective we hope this will improve pain, function and the need for knee replacement surgery for these patients.||PACINO is a trial in patients who have a fracture of the lower leg (tibia) which is not healing. The usual surgical procedure after removing areas of damaged bone is to drill holes in the healthy bone where the two bones meet and fill these holes with the patients bone marrow to try to encourage the growth of new bone to fill the gap. We want to find out whether inserting stem cells grown from the patients bone marrow will make the new bone grow faster. Patients would welcome any decrease in the time they have to spend wearing a metal frame to support their unhealed fracture.</gtr:abstractText><gtr:technicalSummary>The aim of the programme is to improve prevention and treatment for patients with musculoskeletal conditions. These are a major problem both nationally and internationally with a high burden of disability, and will become increasingly important as a consequence of the ageing population.||Arthritis Research UK is one of the largest medical research charities in the UK, funding research into the causes, consequences and treatment of musculoskeletal conditions. In 2008 Arthritis Research UK launched their clinical studies initiative to develop a comprehensive research programme in partnership with the UK Clinical Research Network (CRN), industry and other funders (such as NIHR) that would permit the testing of both new and existing interventions, based on a nationally agreed and scientifically robust research agenda, across the major disease areas of the charitys interests. In achieving this, there would be a transformation of clinical practice in areas of relevance which would drive both knowledge advance and quality of care. All their UK funded trials will be conducted by UKCRC registered trials units. The charity has funded a senior statistician post at the CTU since 2001 to advise researchers developing proposals for these clinical studies.||Osteoarthritis is a common disorder, and at present there are no effective treatments that alter disease pathology. Management of osteoarthritis is primarily aimed at symptom control with the aim to retain or improve joint function. Epidemiological data suggest that low dietary intake of vitamin D and low serum 25-hydroxyvitamin D3 levels are associated with radiological progression in knee osteoarthritis. VIDEO is a three year randomised, double-blind, placebo controlled trial funded by Arthritis Research UK to determine whether vitamin D supplementation of cholecalciferol 800 IU daily can reduce the rate of disease progression and improve symptoms in participants with knee osteoarthritis. The primary outcome measure is radiological progression with secondary endpoints being symptoms and quality of life assessments. As Vitamin D supplementation is safe and cheap, any proven benefit in the management of osteoarthritis will have important relevance to healthcare in the elderly.||Since 2007 the Royal National Orthopaedic Hospital have funded a statistician post to at the CTU to work on orthopaedic studies. A strong research theme of the Royal National Orthopaedic Hospital is a regenerative approach to lesions of cartilage, bone and tendon using cell-based therapies. If such an approach can be made to work this would reduce the need for reconstructive surgery and improve quality of life by reducing the amount of time the patient has to spend with their leg in a metal frame. RNOH have secured MRC funding to conduct a trial (PACINO) of autologous mesenchymal stem cells in fracture non-union. At the end of the trial we will use proteomics to correlate clinical response with cell phenotype. This should enable us to refine cell culture processes, and hence to develop more effective treatments for future trials.||A Phase II trial (SCARAB) of autologous bone marrow derived mesenchymal stem cells mixed with bone stock to improve the regeneration of bone adjacent to the implant in revision hip surgery is being planned. The failure rate of revision hip surgery is high, 25-50% of revision procedures fail, and increasing the regeneration of bone within the impacted graft is crucial for a successful outcome.</gtr:technicalSummary><gtr:fund><gtr:end>2013-07-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>2220920</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal National Orthopaedic Hospital NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with the Royal National Orthopaedic Hospital</gtr:description><gtr:id>A9435DEA-6E87-4570-AB3F-A84736706063</gtr:id><gtr:impact>Mentoring to the RNOH R and D department with the long term aim for them to become a UKCRC Registered Clinical Trials Unit. Improving the quality of clinical trials in orthopaedic surgery.
Pubmed ID: 19721042, 19349298, 20357337</gtr:impact><gtr:outcomeId>DAAA5F7DD56-1</gtr:outcomeId><gtr:partnerContribution>This financial contribution funded a junior statistician based at MRC CTU to support the research at RNOH. The junior statistician spent half their time supporting RNOH projects under my supervision and half their time supporting other MRC CTU projects.</gtr:partnerContribution><gtr:piContribution>Collaboration with researchers to develop funding applications for clinical trials and other well designed studies. The junior statistician taught on MSc courses and ran a regular Statistical Advisory Clinic.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Comprehensive Clinical Trials Unit</gtr:department><gtr:description>UCL Comprehensive Clinical Trials Unit</gtr:description><gtr:id>F955586C-C67F-4292-B0A2-DD6F7E544F0B</gtr:id><gtr:impact>A number of funding applications are in development.</gtr:impact><gtr:outcomeId>b8pzokUHZzT-1</gtr:outcomeId><gtr:partnerContribution>All new funding applications for musculoskeletal trials are collaborations with UCL CCTU</gtr:partnerContribution><gtr:piContribution>I am seconded 0.8 FTE to the UCL Comprehensive Clinical Trials Unit as Head of Statistics</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Arthritis Research UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>arc Clinical Trials Collaboration Senior Statistician</gtr:description><gtr:id>9D1787D8-EC46-4CC5-A27D-B316F734DEE8</gtr:id><gtr:impact>Twenty trials were funded by the arc CTC. Twelve trials have been completed, 2 were stopped early, 3 are in the follow up stage, and 3 are currently recruiting.
Pubmed IDs: 17968938, 16739187, 20102625</gtr:impact><gtr:outcomeId>72741564DF7-1</gtr:outcomeId><gtr:partnerContribution>Provided funding for my post.</gtr:partnerContribution><gtr:piContribution>Work with potential Chief Investigators of all Arthritis Research UK funded multi-centre trials to develope outline and full proposals. To be an observer on the Trial Steering Committee advising on the progress, conduct, analysis and reporting of each trial.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Workshop to develop guidance for internal pilot studies</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>70FBE676-2450-4CA8-91AD-0789DF8E0DCA</gtr:id><gtr:impact>This was a workshop to optimise the design and evaluation of internal pilot work to inform efficient randomised controlled trials. I presented a vignette describing the internal pilot phase and the progression criteria for the TARVA trial. The workshop was funded by the MRC Hubs for Trials Methodology research. A paper summarising the discussion is in preparation</gtr:impact><gtr:outcomeId>56cb12228a20a5.97589661</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>436823</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical Studies, OPTTIRA</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Arthritis Research UK</gtr:fundingOrg><gtr:fundingRef>18813</gtr:fundingRef><gtr:id>EE60AB77-4B6F-4AAA-996B-FF1A8516816E</gtr:id><gtr:outcomeId>tTEMrpiqWMG</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>210089</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical Studies, RAPS</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Arthritis Research UK</gtr:fundingOrg><gtr:fundingRef>19708</gtr:fundingRef><gtr:id>31F03BAD-0ECC-47FE-BB8A-39CE7A7A258E</gtr:id><gtr:outcomeId>NZLW5DKx1cF</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1297038</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HTA , TARVA</gtr:description><gtr:end>2018-05-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>12/35/27</gtr:fundingRef><gtr:id>BAC5CC78-6B0D-4F61-B944-B070CEA7C6B9</gtr:id><gtr:outcomeId>5453d6b02ce725.17545766</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>756700</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Arthritis Research UK Clinical Trial Award, VIDEO</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>Arthritis Research UK</gtr:fundingOrg><gtr:fundingRef>18234</gtr:fundingRef><gtr:id>802CA091-6236-4ED8-9F6F-EBF4B337E4BC</gtr:id><gtr:outcomeId>181A46709590</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2004-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>763736</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Translational Stem Cell Research Committee (TSCRC) Grant, PACINO</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0900880</gtr:fundingRef><gtr:id>414735EF-1592-45FE-BFB7-787620F7C539</gtr:id><gtr:outcomeId>90EC5479F110</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MRC Hub Network Surgical Specialist Methodology workshop at the Royal College of Surgeons of England</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E60220A2-4291-4228-81E4-E4FEEEF12372</gtr:id><gtr:impact>Improvements in the quality of surgical research</gtr:impact><gtr:outcomeId>YS5S2aJALfK</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Quality of life in systemic sclerosis</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>F943B656-425A-4FE0-A5AD-6E4A88543D8D</gtr:id><gtr:impact>Pubmed ID Systematic review: 19644906</gtr:impact><gtr:outcomeId>QGJvU78wgtZ</gtr:outcomeId><gtr:type>Citation in systematic reviews</gtr:type><gtr:url>http://europepmc.org/abstract/MED/19644906</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citation in Cochrane review</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>2DB4292F-1418-4689-9ED4-B93619719C27</gtr:id><gtr:impact>Rehabilitation following lumbar disc surgery</gtr:impact><gtr:outcomeId>56cb206e920e86.03966299</gtr:outcomeId><gtr:type>Citation in systematic reviews</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/pubmed/24627325</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Vascular disease in scleroderma</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>72CE7E6F-59CA-41FC-9108-647D513EE6BB</gtr:id><gtr:impact>Pubmed ID Review: 19067252</gtr:impact><gtr:outcomeId>nR1x5Eatehs</gtr:outcomeId><gtr:type>Citation in clinical reviews</gtr:type><gtr:url>http://europepmc.org/abstract/MED/19067252</gtr:url></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>Vitamin D supplementation may reduce the rate of disease progression and improve symptoms in participants with knee osteoarthritis.</gtr:description><gtr:id>26506878-6F7A-458C-8A73-EC0BE5F450AC</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>YgeNR5FM4Wi</gtr:outcomeId><gtr:stage>Late clinical evaluation</gtr:stage><gtr:status>Closed</gtr:status><gtr:title>VIDEO</gtr:title><gtr:type>Preventative Intervention - Nutrition and Chemoprevention</gtr:type><gtr:yearDevCompleted>2013</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>TARVA is a randomised clinical trial comparing ankle replacement and ankle arthrodesis (fusion) in patients aged 50-85 with end-stage ankle arthritis</gtr:description><gtr:id>34E677FA-E226-4CA4-BB88-AB6E95F4E2C1</gtr:id><gtr:impact>Our main objectives are :
1.to determine which treatment offers better pain free function and quality of life, fewer complications and best value for money;
2.to disseminate the trial findings to the public through the patient group involved with our research as well as through peer reviewed journals, conferences, seminars and meetings.</gtr:impact><gtr:outcomeId>5453d88d93dd39.90864085</gtr:outcomeId><gtr:stage>Late clinical evaluation</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>TARVA</gtr:title><gtr:type>Therapeutic Intervention - Surgery</gtr:type><gtr:url>http://anklearthritis.co.uk</gtr:url><gtr:yearDevCompleted>2013</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>The study questions are: 
1. Do culture-expanded, autologous mesenchymal stem cells (MSC) stimulate healing of nonunions more effectively than unmodified bone marrow? 
2. Does the magnitude of the regenerative response correlate with any identifiable phenotypic features of the implanted cells?</gtr:description><gtr:id>957EE8D8-1EB3-4F83-8785-F018A3BDFD09</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>i28zXToGA5h</gtr:outcomeId><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Closed</gtr:status><gtr:title>PACINO</gtr:title><gtr:type>Therapeutic Intervention - Cellular and gene therapies</gtr:type><gtr:url>http://www.controlled-trials.com/ISRCTN09755245</gtr:url><gtr:yearDevCompleted>2013</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>C4E04A16-400A-4077-87C8-8B8DD28B6586</gtr:id><gtr:title>An evaluation of a postoperative rehabilitation program after spinal surgery and its impact on outcome.</gtr:title><gtr:parentPublicationTitle>Spine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3952192971eaad823df62761afb89f6"><gtr:id>c3952192971eaad823df62761afb89f6</gtr:id><gtr:otherNames>McGregor AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0362-2436</gtr:issn><gtr:outcomeId>pm_12557_27_22024898</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A59209FB-4879-4257-9211-4024908BED2F</gtr:id><gtr:title>Colour doppler ultrasound of the lumbar arteries: a novel application and reproducibility study in healthy subjects.</gtr:title><gtr:parentPublicationTitle>Ultrasound in medicine &amp; biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d4b130d5b71aacda1d18e417b923f49"><gtr:id>9d4b130d5b71aacda1d18e417b923f49</gtr:id><gtr:otherNames>Espahbodi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0301-5629</gtr:issn><gtr:outcomeId>D8C8F79F094</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>251092D6-6E1B-49E4-8CCA-B7E7643CA440</gtr:id><gtr:title>Return to play after lateral meniscectomy compared with medial meniscectomy in elite professional soccer players.</gtr:title><gtr:parentPublicationTitle>The American journal of sports medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b23c8b72383be6cc8ae3969658784d74"><gtr:id>b23c8b72383be6cc8ae3969658784d74</gtr:id><gtr:otherNames>Nawabi DH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0363-5465</gtr:issn><gtr:outcomeId>54513b35d72a69.42964933</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BD9F9F7-C4A1-4485-9567-2E9A027F6CDE</gtr:id><gtr:title>Material loss at the taper junction of retrieved large head metal-on-metal total hip replacements.</gtr:title><gtr:parentPublicationTitle>Journal of orthopaedic research : official publication of the Orthopaedic Research Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c239001a23aae73df6fb363c8cc2ddd"><gtr:id>0c239001a23aae73df6fb363c8cc2ddd</gtr:id><gtr:otherNames>Matthies AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0736-0266</gtr:issn><gtr:outcomeId>54513a3e82b384.38582848</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91BA9522-77B6-4508-B6A6-B4D0E99FB942</gtr:id><gtr:title>Predicting wear and blood metal ion levels in metal-on-metal hip resurfacing.</gtr:title><gtr:parentPublicationTitle>Journal of orthopaedic research : official publication of the Orthopaedic Research Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c239001a23aae73df6fb363c8cc2ddd"><gtr:id>0c239001a23aae73df6fb363c8cc2ddd</gtr:id><gtr:otherNames>Matthies AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0736-0266</gtr:issn><gtr:outcomeId>545139ce97f4f9.60228380</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8CF6828-DA08-4FF2-B6CA-838AA93A3102</gtr:id><gtr:title>Baseline vWF factor predicts the development of elevated pulmonary artery pressure in systemic sclerosis.</gtr:title><gtr:parentPublicationTitle>Rheumatology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9fe6345ca1bc7d3388a8a07010335a5d"><gtr:id>9fe6345ca1bc7d3388a8a07010335a5d</gtr:id><gtr:otherNames>Barnes T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1462-0324</gtr:issn><gtr:outcomeId>pm_12557_27_22596213</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C83B4275-206D-4826-ACBE-3A09038146DB</gtr:id><gtr:title>A correlation between the timing of biopsy after autologous chondrocyte implantation and the histological appearance.</gtr:title><gtr:parentPublicationTitle>The Journal of bone and joint surgery. British volume</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d75f2a632076fc516b57c470d77400fa"><gtr:id>d75f2a632076fc516b57c470d77400fa</gtr:id><gtr:otherNames>Gikas PD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0301-620X</gtr:issn><gtr:outcomeId>1A4C11BE3D9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C377DEF-B312-4081-AD21-C27F30C4F5ED</gtr:id><gtr:title>Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE.</gtr:title><gtr:parentPublicationTitle>Lupus</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09d859c0f8335ca40009b99e4329d87a"><gtr:id>09d859c0f8335ca40009b99e4329d87a</gtr:id><gtr:otherNames>Cohen H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0961-2033</gtr:issn><gtr:outcomeId>56bc6fb665ce23.64807062</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2DD48136-B0D0-42A5-B335-C111391AB72D</gtr:id><gtr:title>A variant in MCF2L is associated with osteoarthritis.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c20fe7feabf2627e2a3f90d986f418d"><gtr:id>3c20fe7feabf2627e2a3f90d986f418d</gtr:id><gtr:otherNames>Day-Williams AG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>5458fdb5204995.51705493</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9576C88B-1803-4F55-A42D-8B93F1E18B19</gtr:id><gtr:title>The effect of FTO variation on increased osteoarthritis risk is mediated through body mass index: a Mendelian randomisation study.</gtr:title><gtr:parentPublicationTitle>Annals of the rheumatic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/563604aabe18251ac9670f0a95ca4c98"><gtr:id>563604aabe18251ac9670f0a95ca4c98</gtr:id><gtr:otherNames>Panoutsopoulou K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0003-4967</gtr:issn><gtr:outcomeId>5458ff912fd580.34722100</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EAE75D7A-B1E0-4AEC-997D-35AA58490AFD</gtr:id><gtr:title>Level of evidence of clinical spinal research and its correlation with journal impact factor.</gtr:title><gtr:parentPublicationTitle>The spine journal : official journal of the North American Spine Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/172d2b106e085182a688395b8def7239"><gtr:id>172d2b106e085182a688395b8def7239</gtr:id><gtr:otherNames>Amiri AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1529-9430</gtr:issn><gtr:outcomeId>doi_12557_013_05_026</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BDBE439-93A5-4787-9AE2-33959C886E5D</gtr:id><gtr:title>Meta-analysis of genome-wide association studies confirms a susceptibility locus for knee osteoarthritis on chromosome 7q22.</gtr:title><gtr:parentPublicationTitle>Annals of the rheumatic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f41551d5aab7d7e9f0f6b8d91ef697d9"><gtr:id>f41551d5aab7d7e9f0f6b8d91ef697d9</gtr:id><gtr:otherNames>Evangelou E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0003-4967</gtr:issn><gtr:outcomeId>545901653ea828.63720903</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02F1ED2F-E661-4157-B78C-53A4C88E189F</gtr:id><gtr:title>MRI characteristics of lipoma and atypical lipomatous tumor/well-differentiated liposarcoma: retrospective comparison with histology and MDM2 gene amplification.</gtr:title><gtr:parentPublicationTitle>Skeletal radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7609c83dd327f0f6385696262c26ee86"><gtr:id>7609c83dd327f0f6385696262c26ee86</gtr:id><gtr:otherNames>Brisson M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0364-2348</gtr:issn><gtr:outcomeId>doi_12557_012_1517_z</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>965A64F8-B9E8-45CE-B536-DDD9C1FA3AF9</gtr:id><gtr:title>Identification of new susceptibility loci for osteoarthritis (arcOGEN): a genome-wide association study.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51af9c896d681ece29bfb49215750405"><gtr:id>51af9c896d681ece29bfb49215750405</gtr:id><gtr:otherNames>arcOGEN Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>5459008ddfbbf7.60897472</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>099D07B0-EDB4-4ACE-BF9A-80AA3C0C5695</gtr:id><gtr:title>EFFECT OF VITAMIN D SUPPLEMENTATION ON RADIOGRAPHIC KNEE OSTEOARTHRITIS</gtr:title><gtr:parentPublicationTitle>OSTEOARTHRITIS AND CARTILAGE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9cf7d3f106903de2b7de7303fe44ee5b"><gtr:id>9cf7d3f106903de2b7de7303fe44ee5b</gtr:id><gtr:otherNames>Arden N. K.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1063-4584</gtr:issn><gtr:outcomeId>56bc72ecbfc263.57876207</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1749D59C-25CD-4AB3-AB0C-A6509B25C351</gtr:id><gtr:title>Single-blind randomized trial of combination antibiotic therapy in rheumatoid arthritis.</gtr:title><gtr:parentPublicationTitle>The Journal of rheumatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77087218d44859ac333513ba4b2776c8"><gtr:id>77087218d44859ac333513ba4b2776c8</gtr:id><gtr:otherNames>Gompels LL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0315-162X</gtr:issn><gtr:outcomeId>66D55C696DC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8522C20-4CB0-4367-ABDF-0395ABDCA1FC</gtr:id><gtr:title>Raps (rivaroxaban in antiphospholipid syndrome): a prospective randomised controlled phase II/III clinical trial of rivaroxaban vs. warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE</gtr:title><gtr:parentPublicationTitle>JOURNAL OF THROMBOSIS AND HAEMOSTASIS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b4112b0339ae57589cec8889beb7423"><gtr:id>7b4112b0339ae57589cec8889beb7423</gtr:id><gtr:otherNames>Cohen H.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1538-7933</gtr:issn><gtr:outcomeId>56bc71fb0540a8.50044803</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D07F20D-7B6D-4E71-955A-57A1B0C77E21</gtr:id><gtr:title>The reliability and variation of measurements of the os calcis angles in children.</gtr:title><gtr:parentPublicationTitle>The Journal of bone and joint surgery. British volume</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8f638258f662d9a760218fb466303f6"><gtr:id>f8f638258f662d9a760218fb466303f6</gtr:id><gtr:otherNames>Clint SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0301-620X</gtr:issn><gtr:outcomeId>eDAYHoat3oE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA82DC10-B6B8-422A-A2C1-481147F66278</gtr:id><gtr:title>Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril.</gtr:title><gtr:parentPublicationTitle>Arthritis and rheumatism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7af88217801e6843ddfec9dfdb7a0f4"><gtr:id>f7af88217801e6843ddfec9dfdb7a0f4</gtr:id><gtr:otherNames>Gliddon AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0004-3591</gtr:issn><gtr:outcomeId>3DFD33417CA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8AF2AEF-C443-407C-8A55-321BF056B771</gtr:id><gtr:title>Influence of clinical features on the health status of patients with limited cutaneous systemic sclerosis.</gtr:title><gtr:parentPublicationTitle>Arthritis and rheumatism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7af88217801e6843ddfec9dfdb7a0f4"><gtr:id>f7af88217801e6843ddfec9dfdb7a0f4</gtr:id><gtr:otherNames>Gliddon AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0004-3591</gtr:issn><gtr:outcomeId>98C4F1E3347</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F66661B-B427-4DC5-8F2D-0305A2978FEE</gtr:id><gtr:title>Clinical testing of ulnar collateral ligament injuries of the thumb.</gtr:title><gtr:parentPublicationTitle>The Journal of hand surgery, European volume</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/57e6486e70982e6a6b25c1ee69011a50"><gtr:id>57e6486e70982e6a6b25c1ee69011a50</gtr:id><gtr:otherNames>Malik AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0266-7681</gtr:issn><gtr:outcomeId>7C9185AA9C8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>368B9E80-EDCA-4086-8C78-8835E61F9F6C</gtr:id><gtr:title>Anatomical distribution of synovitis in knee osteoarthritis and its association with joint effusion assessed on non-enhanced and contrast-enhanced MRI.</gtr:title><gtr:parentPublicationTitle>Osteoarthritis and cartilage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24c7d356924509ebfd4c99fba7dc158d"><gtr:id>24c7d356924509ebfd4c99fba7dc158d</gtr:id><gtr:otherNames>Roemer FW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1063-4584</gtr:issn><gtr:outcomeId>5458fd7ca4acc8.60341421</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D14B1C27-E7AC-4560-B7AF-FCD67D04BF68</gtr:id><gtr:title>Interventions in randomised controlled trials in surgery: issues to consider during trial design.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/358b24fc3fa6ab7e39ee3c04a3952913"><gtr:id>358b24fc3fa6ab7e39ee3c04a3952913</gtr:id><gtr:otherNames>Blencowe NS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>56bb75db293968.27125554</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D43EBDFA-1302-422D-ABEA-F05AA925A205</gtr:id><gtr:title>Patients' views on an education booklet following spinal surgery.</gtr:title><gtr:parentPublicationTitle>European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3952192971eaad823df62761afb89f6"><gtr:id>c3952192971eaad823df62761afb89f6</gtr:id><gtr:otherNames>McGregor AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0940-6719</gtr:issn><gtr:outcomeId>pm_12557_27_22382727</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA83BE66-F1DE-4F63-93B1-37DCDC97058C</gtr:id><gtr:title>Does source of funding and conflict of interest influence the outcome and quality of spinal research?</gtr:title><gtr:parentPublicationTitle>The spine journal : official journal of the North American Spine Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/172d2b106e085182a688395b8def7239"><gtr:id>172d2b106e085182a688395b8def7239</gtr:id><gtr:otherNames>Amiri AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1529-9430</gtr:issn><gtr:outcomeId>54513bbc2bd408.34682676</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62FE90B4-5FD9-4A3D-ACEA-66409D296EAE</gtr:id><gtr:title>OPTIMIZING TREATMENT WITH TNF INHIBITORS IN RHEUMATOID ARTHRITIS: IS DOSE TAPERING PRACTICAL IN OPTIMAL RESPONDERS? THE OPTTIRA TRIAL</gtr:title><gtr:parentPublicationTitle>RHEUMATOLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8aad2b77a16d5af48131e818b4c54a1d"><gtr:id>8aad2b77a16d5af48131e818b4c54a1d</gtr:id><gtr:otherNames>Galloway James</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1462-0324</gtr:issn><gtr:outcomeId>56bc7246302528.14701897</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15ED697C-D29F-492E-BC10-54DF83F26C6B</gtr:id><gtr:title>Perioperative buffered versus non-buffered fluid administration for surgery in adults.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9901f7b101dac93cc8eabcd79ef267c5"><gtr:id>9901f7b101dac93cc8eabcd79ef267c5</gtr:id><gtr:otherNames>Burdett E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>doi_12557_04089_pub2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>337E57BB-34D9-442C-AA77-A41DC0E9BF3B</gtr:id><gtr:title>Associations Between Clinical Evidence of Inflammation and Synovitis in Symptomatic Knee Osteoarthritis: A Cross-Sectional Substudy.</gtr:title><gtr:parentPublicationTitle>Arthritis care &amp; research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d58e0237e40d4826d5db97c32ae886e"><gtr:id>5d58e0237e40d4826d5db97c32ae886e</gtr:id><gtr:otherNames>Wallace G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2151-464X</gtr:issn><gtr:outcomeId>58b5973035b146.66638983</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A245AAB-9334-4C8E-8CED-21D45A22AFD1</gtr:id><gtr:title>Assessment of osteoarthritis candidate genes in a meta-analysis of nine genome-wide association studies.</gtr:title><gtr:parentPublicationTitle>Arthritis &amp; rheumatology (Hoboken, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/600db8064142f4f54a9f5577f16bc9ec"><gtr:id>600db8064142f4f54a9f5577f16bc9ec</gtr:id><gtr:otherNames>Rodriguez-Fontenla C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2326-5191</gtr:issn><gtr:outcomeId>5458fd34eed581.73179833</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14B23D62-1DE3-4F42-85CB-4885C79994C4</gtr:id><gtr:title>Function after spinal treatment, exercise, and rehabilitation: cost-effectiveness analysis based on a randomized controlled trial.</gtr:title><gtr:parentPublicationTitle>Spine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d0d85071e75916a8f09a9815ed0c74e"><gtr:id>7d0d85071e75916a8f09a9815ed0c74e</gtr:id><gtr:otherNames>Morris S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0362-2436</gtr:issn><gtr:outcomeId>BxhWCVFXLwy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86B12EDE-27ED-4DB9-B65F-3CF6456C30F2</gtr:id><gtr:title>Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial.</gtr:title><gtr:parentPublicationTitle>The Lancet. Haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09d859c0f8335ca40009b99e4329d87a"><gtr:id>09d859c0f8335ca40009b99e4329d87a</gtr:id><gtr:otherNames>Cohen H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2352-3026</gtr:issn><gtr:outcomeId>58b5973007d501.99675572</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>668DF979-A16C-44A2-B8B2-AF50A4BA5D39</gtr:id><gtr:title>Function after spinal treatment, exercise and rehabilitation (FASTER): improving the functional outcome of spinal surgery.</gtr:title><gtr:parentPublicationTitle>BMC musculoskeletal disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3952192971eaad823df62761afb89f6"><gtr:id>c3952192971eaad823df62761afb89f6</gtr:id><gtr:otherNames>McGregor AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1471-2474</gtr:issn><gtr:outcomeId>stQHJEBQJTZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79438D05-16A7-4003-A140-69B10AC44B65</gtr:id><gtr:title>Total ankle replacement versus arthrodesis (TARVA): protocol for a multicentre randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1bdb3300c1e8149c64bc7ecbba459b7a"><gtr:id>1bdb3300c1e8149c64bc7ecbba459b7a</gtr:id><gtr:otherNames>Goldberg AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>58b5972fc05010.39208462</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34A91B69-0319-4C27-95B7-79B8EB784070</gtr:id><gtr:title>Postoperative spinal epidural hematoma (SEH): incidence, risk factors, onset, and management.</gtr:title><gtr:parentPublicationTitle>The spine journal : official journal of the North American Spine Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/172d2b106e085182a688395b8def7239"><gtr:id>172d2b106e085182a688395b8def7239</gtr:id><gtr:otherNames>Amiri AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1529-9430</gtr:issn><gtr:outcomeId>doi_12557_012_10_028</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EEFB66DE-EE5C-45AB-905C-C9F724E2CC19</gtr:id><gtr:title>Insights into the genetic architecture of osteoarthritis from stage 1 of the arcOGEN study.</gtr:title><gtr:parentPublicationTitle>Annals of the rheumatic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/563604aabe18251ac9670f0a95ca4c98"><gtr:id>563604aabe18251ac9670f0a95ca4c98</gtr:id><gtr:otherNames>Panoutsopoulou K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0003-4967</gtr:issn><gtr:outcomeId>54590129571756.74739818</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71A43517-DA77-4257-98EB-DEBE969A03CB</gtr:id><gtr:title>Evaluation of the genetic overlap between osteoarthritis with body mass index and height using genome-wide association scan data.</gtr:title><gtr:parentPublicationTitle>Annals of the rheumatic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88ac149523104bc6f39b0c1de3d152d1"><gtr:id>88ac149523104bc6f39b0c1de3d152d1</gtr:id><gtr:otherNames>Elliott KS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0003-4967</gtr:issn><gtr:outcomeId>545900c3420af6.86114558</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCB070C6-161E-4720-A200-D35D6D0A9D56</gtr:id><gtr:title>ISSLS prize winner: Function After Spinal Treatment, Exercise, and Rehabilitation (FASTER): a factorial randomized trial to determine whether the functional outcome of spinal surgery can be improved.</gtr:title><gtr:parentPublicationTitle>Spine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3952192971eaad823df62761afb89f6"><gtr:id>c3952192971eaad823df62761afb89f6</gtr:id><gtr:otherNames>McGregor AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0362-2436</gtr:issn><gtr:outcomeId>Y7uYzvPLQw4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A036375A-3F69-453F-BED9-0FA5BD0BC8AB</gtr:id><gtr:title>RAPS: a prospective randomised controlled phase II/III clinical trial of rivaroxaban vs. warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE</gtr:title><gtr:parentPublicationTitle>JOURNAL OF THROMBOSIS AND HAEMOSTASIS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b4112b0339ae57589cec8889beb7423"><gtr:id>7b4112b0339ae57589cec8889beb7423</gtr:id><gtr:otherNames>Cohen H.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1538-7933</gtr:issn><gtr:outcomeId>56bc73d2ca8f95.46336276</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67712DF6-87F7-4D33-9D85-A298112413DC</gtr:id><gtr:title>Second-line agents in myositis: 1-year factorial trial of additional immunosuppression in patients who have partially responded to steroids.</gtr:title><gtr:parentPublicationTitle>Rheumatology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c49755f7f5b167b37c218aa065bc555"><gtr:id>5c49755f7f5b167b37c218aa065bc555</gtr:id><gtr:otherNames>Ibrahim F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1462-0324</gtr:issn><gtr:outcomeId>56bb75dac07f61.04176399</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EFB70FE1-A2CD-4B95-A9EF-353A4519637D</gtr:id><gtr:title>Levels of evidence in foot and ankle surgery literature: progress from 2000 to 2010?</gtr:title><gtr:parentPublicationTitle>The Journal of bone and joint surgery. American volume</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31d3227f713b0265526606b61c50aec8"><gtr:id>31d3227f713b0265526606b61c50aec8</gtr:id><gtr:otherNames>Zaidi R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9355</gtr:issn><gtr:outcomeId>pm_12557_27_22855001</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BED4558F-3E52-4E94-88C9-E3FC98B6A39A</gtr:id><gtr:title>A comparison of the diagnostic accuracy of MARS MRI and ultrasound of the painful metal-on-metal hip arthroplasty.</gtr:title><gtr:parentPublicationTitle>Acta orthopaedica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da3307bf1e37db1be29018900ebd5a7c"><gtr:id>da3307bf1e37db1be29018900ebd5a7c</gtr:id><gtr:otherNames>Siddiqui IA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1745-3674</gtr:issn><gtr:outcomeId>54513b94ee2812.48732426</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F967300-8E59-48EC-92A7-4FD24DCE05E2</gtr:id><gtr:title>No evidence of an association between mitochondrial DNA variants and osteoarthritis in 7393 cases and 5122 controls.</gtr:title><gtr:parentPublicationTitle>Annals of the rheumatic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65eb931f142b9d0a96c1e2e4b5b1f6a7"><gtr:id>65eb931f142b9d0a96c1e2e4b5b1f6a7</gtr:id><gtr:otherNames>Hudson G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0003-4967</gtr:issn><gtr:outcomeId>545901ca74b7e6.25858659</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2429DF34-12F4-46E9-BA8C-5510E27B77F7</gtr:id><gtr:title>Rehabilitation following surgery for lumbar spinal stenosis.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3952192971eaad823df62761afb89f6"><gtr:id>c3952192971eaad823df62761afb89f6</gtr:id><gtr:otherNames>McGregor AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>5451370ecbf919.21170979</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3460BE8-7494-4E32-A17A-1F6F4AAD9000</gtr:id><gtr:title>The outcome of total ankle replacement: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>The bone &amp; joint journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31d3227f713b0265526606b61c50aec8"><gtr:id>31d3227f713b0265526606b61c50aec8</gtr:id><gtr:otherNames>Zaidi R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2049-4394</gtr:issn><gtr:outcomeId>54513a11d4e6e3.73713353</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>450E471F-721B-4724-9018-D266EEABAAC2</gtr:id><gtr:title>Antinuclear antibodies and clinical associations in a british cohort with limited cutaneous systemic sclerosis.</gtr:title><gtr:parentPublicationTitle>The Journal of rheumatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7af88217801e6843ddfec9dfdb7a0f4"><gtr:id>f7af88217801e6843ddfec9dfdb7a0f4</gtr:id><gtr:otherNames>Gliddon AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0315-162X</gtr:issn><gtr:outcomeId>BHSS9EYsF5A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B823A2A6-5416-459C-87D9-B32FEE84F6E1</gtr:id><gtr:title>A randomised controlled trial of subcutaneous sodium salicylate therapy for osteoarthritis of the thumb.</gtr:title><gtr:parentPublicationTitle>Postgraduate medical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/afdb334d99bab3afd9ec9dce26dea3c2"><gtr:id>afdb334d99bab3afd9ec9dce26dea3c2</gtr:id><gtr:otherNames>Smith AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0032-5473</gtr:issn><gtr:outcomeId>LbXNsSXuLtd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8C32BE8-D759-4377-A127-A8EB9C335980</gtr:id><gtr:title>Rehabilitation following surgery for lumbar spinal stenosis. A Cochrane review.</gtr:title><gtr:parentPublicationTitle>Spine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3952192971eaad823df62761afb89f6"><gtr:id>c3952192971eaad823df62761afb89f6</gtr:id><gtr:otherNames>McGregor AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0362-2436</gtr:issn><gtr:outcomeId>545136b7d06e56.26230971</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70DBB171-750F-4B6F-9466-1A1A6639B329</gtr:id><gtr:title>An exploration of patients' expectation of and satisfaction with surgical outcome.</gtr:title><gtr:parentPublicationTitle>European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3952192971eaad823df62761afb89f6"><gtr:id>c3952192971eaad823df62761afb89f6</gtr:id><gtr:otherNames>McGregor AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0940-6719</gtr:issn><gtr:outcomeId>545136b8115040.11438360</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>593311B0-F785-4B72-B6F5-525DE90E9553</gtr:id><gtr:title>Color Doppler ultrasonography of lumbar artery blood flow in patients with low back pain.</gtr:title><gtr:parentPublicationTitle>Spine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d4b130d5b71aacda1d18e417b923f49"><gtr:id>9d4b130d5b71aacda1d18e417b923f49</gtr:id><gtr:otherNames>Espahbodi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0362-2436</gtr:issn><gtr:outcomeId>doi_12557_31827ecd6e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5CD13175-088E-427B-A948-A005C646882F</gtr:id><gtr:title>The effect of vitamin D supplementation on knee osteoarthritis, the VIDEO study: a randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Osteoarthritis and cartilage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ded21e797edb1e4cac2ee83bc0ddfff"><gtr:id>4ded21e797edb1e4cac2ee83bc0ddfff</gtr:id><gtr:otherNames>Arden NK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1063-4584</gtr:issn><gtr:outcomeId>58b5972f9188d3.36437544</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42E0194B-617D-4F9D-9E22-A12DA7BA9A01</gtr:id><gtr:title>Optimizing treatment with tumour necrosis factor inhibitors in rheumatoid arthritis-a proof of principle and exploratory trial: is dose tapering practical in good responders?</gtr:title><gtr:parentPublicationTitle>Rheumatology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c49755f7f5b167b37c218aa065bc555"><gtr:id>5c49755f7f5b167b37c218aa065bc555</gtr:id><gtr:otherNames>Ibrahim F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1462-0324</gtr:issn><gtr:outcomeId>5a8466eece39a4.85420299</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05820D5D-C801-4F8E-8E49-0F54FEF66DCB</gtr:id><gtr:title>Randomised double-blind trial of combination antibiotic therapy in rheumatoid arthritis.</gtr:title><gtr:parentPublicationTitle>International journal of rheumatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b57ccfaab2cedb549155707885444d88"><gtr:id>b57ccfaab2cedb549155707885444d88</gtr:id><gtr:otherNames>Smith A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1687-9260</gtr:issn><gtr:outcomeId>XHtRqubd7th</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12B751CF-2549-4A6F-8E7B-667D443D0ACC</gtr:id><gtr:title>A randomized, double-blind, placebo-controlled trial of low-dose oral prednisolone for treating painful hand osteoarthritis.</gtr:title><gtr:parentPublicationTitle>Rheumatology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f58b422ba7ddc0acfc4389328cb32b2"><gtr:id>6f58b422ba7ddc0acfc4389328cb32b2</gtr:id><gtr:otherNames>Wenham CY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1462-0324</gtr:issn><gtr:outcomeId>pm_12557_27_22956551</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U122886349</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>149FA87E-B8CD-4FFC-B515-EAD312BED03B</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Musculoskeletal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>A056411B-DD7A-4062-BE33-7849FBC9BFA7</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>5.9  Resources and infrastructure (development of treatments)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>0CDFB83C-594C-4860-B0BE-C82CA4D45B6B</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>6.2  Cellular and gene therapies</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>208C592B-C1B7-4E87-A19A-04E8D9458E50</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>6.9  Resources and infrastructure (evaluation of treatments)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>